Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Barclays raised the firm’s price target on Becton Dickinson (BDX) to $279 from $278 and keeps an Overweight rating on the shares. The firm says ...
American medical technology (MedTech) company Becton Dickinson (BDX) plans to split from its bioscience and diagnostic ...
Activist Starboard took a position in Becton Dickinson, calling for the company to sell its life sciences business. The ...
BCAL Diagnostics Limited ( ASX:BDX ) is possibly approaching a major achievement in its business, so we would like ...
Shares of Becton Dickinson & Co. BDX slipped 1.60% to $225.85 Wednesday, on what proved to be an all-around rough trading ...
At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website, investors.bd.com or by phone at 1-800-839-2486 for domestic calls and area ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Becton Dickinson and Company BDX, popularly known as BD, is scheduled to report first-quarter fiscal 2025 results on Feb. 6, before market open. See the Zacks Earnings Calendar to stay ahead of ...